129 related articles for article (PubMed ID: 2357765)
1. Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.
Parti R; Wolf W
Cancer Chemother Pharmacol; 1990; 26(3):188-92. PubMed ID: 2357765
[TBL] [Abstract][Full Text] [Related]
2. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
Fichtinger-Schepman AM; Vendrik CP; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; Claessen AM; van der Velde-Visser SD; de Groot G; Wubs KL; Steerenberg PA
Cancer Res; 1989 Jun; 49(11):2862-7. PubMed ID: 2720647
[TBL] [Abstract][Full Text] [Related]
3. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.
Vannozzi MO; Ottone M; Mariggiò MA; Cafaggi S; Parodi B; Cilli M; Lindup E; Viale M
Anticancer Res; 2003; 23(2B):1509-16. PubMed ID: 12820417
[TBL] [Abstract][Full Text] [Related]
5. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
Los G; Mutsaers PH; Lenglet WJ; Baldew GS; McVie JG
Cancer Chemother Pharmacol; 1990; 25(6):389-94. PubMed ID: 2311166
[TBL] [Abstract][Full Text] [Related]
6. cis-Platinum: subcellular distribution and binding to cytosolic ligands.
Sharma RP; Edwards IR
Biochem Pharmacol; 1983 Sep; 32(18):2665-9. PubMed ID: 6313005
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
Vadiei K; Siddik ZH; Khokhar AR; al-Baker S; Sampedro F; Perez-Soler R
Cancer Chemother Pharmacol; 1992; 30(5):365-9. PubMed ID: 1505075
[TBL] [Abstract][Full Text] [Related]
8. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
[TBL] [Abstract][Full Text] [Related]
9. Intracellular metabolites of cisplatin in the rat kidney.
Mistry P; Lee C; McBrien DC
Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
[TBL] [Abstract][Full Text] [Related]
10. [Basic studies on optimal intra-arterial infusion rate of cisplatin].
Kishimoto S; Fukushima S; Hayashi Y; Nakano M; Miyazaki K; Okamura H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2788-91. PubMed ID: 2782889
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats.
Zicca A; Cafaggi S; Mariggiò MA; Vannozzi MO; Ottone M; Bocchini V; Caviglioli G; Viale M
Eur J Pharmacol; 2002 May; 442(3):265-72. PubMed ID: 12065080
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
Uozumi J; Litterst CL
Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
[TBL] [Abstract][Full Text] [Related]
13. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Zuhowski EG; Pluim D; Joseph E; Hamburger DR; Working PK; Colbern G; Tonda ME; Potter DM; Eiseman JL
Cancer Chemother Pharmacol; 2004 Apr; 53(4):329-36. PubMed ID: 14673619
[TBL] [Abstract][Full Text] [Related]
14. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9L malignant glioma.
Nakashima M; Shibata S; Tokunaga Y; Fujita H; Anda T; Arizono K; Tomiyama N; Sasaki H; Ichikawa M
J Pharm Pharmacol; 1997 Aug; 49(8):777-80. PubMed ID: 9379355
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Pt in the urine and kidney of the cisplatin treated rat.
Mason RW; Hogg SJ; Edwards IR
Toxicology; 1986 Feb; 38(2):219-26. PubMed ID: 3945972
[TBL] [Abstract][Full Text] [Related]
16. Distribution of platinum between nuclear and cytosolic fractions - Can subcellular fractionation be performed quantitatively?
Dam CS; Lambert IH; Gammelgaard B; Stürup S
J Pharm Biomed Anal; 2019 Feb; 165():82-89. PubMed ID: 30508755
[TBL] [Abstract][Full Text] [Related]
17. [Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
Civalleri D; Esposito M; De Cian F; Balletto N; Vannozzi MO; Mondini G; Carrabetta S; Bocchio MM
G Chir; 1997 Apr; 18(4):175-81. PubMed ID: 9303630
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
19. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
[TBL] [Abstract][Full Text] [Related]
20. [Studies on pharmacokinetics of platinum after internal iliac artery infusion of cisplatin in rabbits].
Kanamori Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jan; 45(1):31-7. PubMed ID: 8436840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
